Blockchain Registration Transaction Record

Flow Cytometry Diagnostics Market to Reach $3.5B by 2036

Flow cytometry diagnostics market to grow from $1.5B in 2026 to $3.5B by 2036 at 8.9% CAGR. Driven by hematologic malignancy testing, MRD monitoring, and workflow reproducibility. Key players: BD, Beckman Coulter, Sysmex.

This news matters because flow cytometry diagnostics are critical for detecting and monitoring blood cancers, guiding treatment decisions, and improving patient survival rates. As the market grows, healthcare providers will gain access to more standardized and reliable testing, enhancing diagnostic accuracy and efficiency. For patients, this means faster, more precise diagnoses and better monitoring of disease progression, ultimately leading to improved outcomes in oncology, immunology, and infectious diseases.